153 results
Page 3 of 8
8-K
EX-99.1
ckyy hd709ffr3csr
6 Aug 19
Results of Operations and Financial Condition
8:15am
8-K
EX-99.1
vjz82r25
1 May 19
Alnylam Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Period Activity
8:45am
PRER14A
58jus8461r5gp6592he
18 Mar 19
Preliminary revised proxy
5:24pm
PRE 14A
9b7nh1
11 Mar 19
Preliminary proxy
5:07pm
8-K
EX-99.1
5wjsr697yt88 duzw
7 Feb 19
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-1.1
itu5moqajsn95hpahhua
15 Jan 19
Entry into a Material Definitive Agreement
5:19pm
424B5
70elyc9oh w7dxu4zbx
15 Jan 19
Prospectus supplement for primary offering
5:14pm
424B5
gyaz9bp65s9 kgj0v
14 Jan 19
Prospectus supplement for primary offering
4:41pm
8-K
EX-99.1
nglu0pkbzg jqqxm
10 Aug 18
ONPATTROâ„¢ (patisiran) for the Treatment of the Polyneuropathy of Hereditary
3:45pm
8-K
EX-99.1
ja1hu8zw
3 May 18
Alnylam Pharmaceuticals Reports First Quarter 2018 Financial Results and Highlights Recent Period Activity
4:15pm